eCase Challenge 2: Managing Insomnia: Practical Considerations for Effective Patient Care
This self-assessment CME activity focuses on practical considerations for the effective management of insomnia disorders, highlighting clinical implications of different mechanisms of action of the various pharmacotherapies for insomnia.

Managing Insomnia: Practical Considerations for Effective Patient Care

Loretta J. Colvin, MS, APRN-BC;Lawrence Herman, MPA, PA-C, DFAAPA

This activity focuses on practical considerations for the effective management of insomnia disorders. Insomnia is often underdiagnosed or undiagnosed in a clinic setting, as diagnosis is based on patient self-reported difficulty with sleep initiation, maintenance, or quality that occurs despite sufficient opportunity for sleep. This activity will identify effective methods of questioning patients to assess their sleep, describe the clinical implications of different mechanisms of action of the various pharmacotherapies for insomnia, and will assist PAs and NPs in applying the criteria for the diagnosis of insomnia disorders, formulating treatment plans based on the patients’ presentation and concerns, and setting appropriate patient expectations when starting or switching to various pharmacologic options for insomnia.

Educational Objectives

At the conclusion of this activity, the PA should be better able to:
  • Identify effective methods of questioning patients to assess their sleep.
  • Apply criteria for the diagnosis of insomnia disorders.
  • Describe the clinical implications of different mechanisms of action of various pharmacotherapies for insomnia.
  • Formulate insomnia treatment plans based on patients’ presentation and concerns.
  • Set appropriate patient expectations when starting or switching to various pharmacologic options for insomnia.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 0.50 AAPA Category 1 Self-Assessment CME credit by the AAPA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs. Approval is valid until December 31, 2018.

Responsibility Statement

AAPA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Loretta J. Colvin, MS, APRN-BC
Assistant Clinical Professor
Coordinator – Acute Care Nurse Practitioner Program
Catherine McAuley School of Nursing
Maryville University
Nurse Practitioner
Clayton Sleep Institute
St. Louis, Missouri
No relationship with any commercial interests whose products or services may be mentioned during this presentation.

Lawrence Herman, MPA, PA-C, DFAAPA
Dean and Professor
College of Health Sciences
PA Studies
Gardner-Webb University
Boiling Springs, North Carolina
Consultant – Merck, Novo Nordisk, Regeneron; Speaker’s Bureau – Novo Nordisk

Activity Planners

Michael Speidel, Medical Logix, LLC and Nancy Baxter, Baxter Medical Communications, LLC, have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

AAPA Staff Activity Planners

Daniel Pace and Jennifer Williams have no relationship with any commercial interests whose products or services may be mentioned during this presentation.

Off-Label/Unapproved Product(s) Discussion

Loretta J. Colvin: OTC’s, antidepressants, antipsychotics and antiepileptics
Lawrence Herman: OTC’s, antidepressants, antipsychotics and antiepileptics

Disclaimer

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

Supported by an independent educational grant from Merck.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.



Type:     Internet Activity (Enduring Material)
1451 Registered Users